Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00547404
Recruitment Status : Withdrawn (Not to expose the patients to subtherapeutic dose)
First Posted : October 22, 2007
Last Update Posted : April 23, 2009
Information provided by:
Piramal Enterprises Limited

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2009
  Estimated Study Completion Date : July 2010